Healthy Participants

AUG 20, 2026 · PHASE 1 TRIAL

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

ClinicalTrials.gov

Phase 1 bioavailability study in healthy volunteers with no results posted; registry record only documents planned pharmacokinetic endpoints without outcome data.

AUG 18, 2026 · PHASE 1 TRIAL

A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

ClinicalTrials.gov

This is a Phase 1 drug–drug interaction study still recruiting, with no results posted; it measures pharmacokinetic surrogates in a small healthy population and cannot yet inform clinical practice.

AUG 14, 2026 · PHASE 1 TRIAL

Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants

ClinicalTrials.gov

This is a Phase 1 trial registration with no reported results; it describes a planned study of safety and tolerability in healthy and overweight/obese participants.

AUG 13, 2026 · PHASE 1 TRIAL

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

ClinicalTrials.gov

Phase 1 bioavailability study in healthy volunteers with surrogate endpoints (plasma concentrations); no results posted in this registry record.

AUG 11, 2026 · PHASE 1 TRIAL

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease

ClinicalTrials.gov

This is an early-phase, first-in-human Phase 1/1b trial registration with no results posted; it is designed to establish safety, tolerability, and dose-range, not to evaluate efficacy.

AUG 10, 2026 · PHASE 1 TRIAL

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

ClinicalTrials.gov

This is a Phase 1 first-in-human study of a novel drug in healthy volunteers; no results are posted in this registry record, and the study is still recruiting.